RA0780

antibody from Oursmab

Targeting: TNFRSF8 CD30, D1S166E, KI-1

Western blot (Data presented on provider website)

ELISA (Recommended by provider)

Immunocytochemistry (Recommended by provider)

Flow cytometry (Recommended by provider)

Functional assay (Recommended by provider)

Antibody Data

Product number

RA0780

Provider

Oursmab

Product name

Iratumumab (Biosimilar Reference Antibody) (TNFRSF8)

Antibody type

Monoclonal

Description

Iratumumab (development code MDX-060) is an investigational, human anti-CD30 immunoglobulin G1 kappa (IgG1¦Ê) monoclonal antibody developed for the treatment of CD30-expressing lymphomas. It functions as a targeted immunotherapeutic agent against the CD30 antigen. By binding with high affinity to CD30 on the surface of tumor cells, iratumumab exerts its antitumor effects through multiple potential mechanisms.

Reactivity

Human

Isotype

IgG

Vial size

100 ¦Ìg,1 mg,5 mg,10 mg,25 mg,50 mg,100 mg

Concentration

Bottled at the concentration indicated on the vial.

Storage

Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.